0.9201
前日終値:
$0.9783
開ける:
$0.9805
24時間の取引高:
471.66K
Relative Volume:
0.75
時価総額:
$97.18M
収益:
$100.56M
当期純損益:
$-119.05M
株価収益率:
-0.748
EPS:
-1.23
ネットキャッシュフロー:
$-231.16M
1週間 パフォーマンス:
+1.75%
1か月 パフォーマンス:
-33.33%
6か月 パフォーマンス:
-82.13%
1年 パフォーマンス:
-81.85%
Alector Inc Stock (ALEC) Company Profile
名前
Alector Inc
セクター
電話
415-231-5660
住所
131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO
ALEC を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
ALEC
Alector Inc
|
0.9201 | 97.18M | 100.56M | -119.05M | -231.16M | -1.23 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
489.10 | 127.47B | 11.02B | -535.60M | -978.00M | -2.20 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
563.16 | 62.43B | 14.20B | 4.41B | 3.54B | 38.28 |
![]()
ARGX
Argen X Se Adr
|
596.20 | 37.03B | 2.19B | 833.04M | -1.28B | 12.71 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
234.56 | 31.06B | 2.25B | -278.16M | -42.59M | -2.17 |
![]()
ONC
Beigene Ltd Adr
|
230.98 | 26.16B | 3.81B | -644.79M | -669.77M | -6.24 |
Alector Inc Stock (ALEC) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2024-12-17 | ダウングレード | Mizuho | Outperform → Neutral |
2024-12-16 | ダウングレード | Stifel | Buy → Hold |
2024-12-04 | ダウングレード | BofA Securities | Neutral → Underperform |
2024-11-29 | 繰り返されました | H.C. Wainwright | Buy |
2024-11-26 | ダウングレード | Morgan Stanley | Equal-Weight → Underweight |
2023-12-14 | アップグレード | Stifel | Hold → Buy |
2023-12-12 | 開始されました | Deutsche Bank | Buy |
2023-09-25 | 開始されました | Goldman | Sell |
2023-09-22 | 開始されました | Cantor Fitzgerald | Overweight |
2023-01-06 | ダウングレード | BofA Securities | Buy → Neutral |
2022-09-09 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
2022-07-07 | 開始されました | Mizuho | Buy |
2022-04-13 | 開始されました | Goldman | Sell |
2022-03-08 | ダウングレード | Stifel | Buy → Hold |
2021-09-27 | 開始されました | William Blair | Outperform |
2021-01-15 | 再開されました | BofA Securities | Buy |
2020-06-24 | 開始されました | H.C. Wainwright | Buy |
2020-04-28 | 開始されました | Goldman | Buy |
2020-03-06 | 開始されました | Citigroup | Buy |
2020-02-27 | 開始されました | Barclays | Overweight |
2020-02-19 | 開始されました | Stifel | Buy |
2019-11-21 | 開始されました | BTIG Research | Buy |
2019-03-04 | 開始されました | Barclays | Overweight |
2019-03-04 | 開始されました | BofA/Merrill | Buy |
2019-03-04 | 開始されました | Morgan Stanley | Overweight |
2019-03-04 | 開始されました | SVB Leerink | Outperform |
すべてを表示
Alector Inc (ALEC) 最新ニュース
What Analysts Were Expecting After Alector Inc (NASDAQ: ALEC) fell -5.95% - stocksregister.com
Alector Completes Enrollment for Phase 2 Alzheimer's Trial of AL101 - MarketScreener
Alector Announces Completion of Enrollment in the - GlobeNewswire
Alector (ALEC) Completes Enrollment for Alzheimer's Drug Trial | ALEC Stock News - GuruFocus
Major Milestone: Alector's Innovative Alzheimer's Drug Trial Hits Full Enrollment Ahead of Schedule - Stock Titan
Alector stock hits 52-week low at $0.99 amid sharp decline By Investing.com - Investing.com South Africa
Alector stock hits 52-week low at $0.99 amid sharp decline - Investing.com India
Alector, Inc. (NASDAQ:ALEC) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat
Finance Watch: As Stocks Tumble, Offerings Slow, Financial Alternatives Rise - insights.citeline.com
Frontotemporal Dementia Pipeline 2025: Key Companies, MOA, - openPR.com
Brokerages Set Alector, Inc. (NASDAQ:ALEC) Price Target at $3.50 - Defense World
Alector stock hits 52-week low at $1.24 amid market challenges - Investing.com
Charles Schwab Investment Management Inc. Reduces Stock Position in Alector, Inc. (NASDAQ:ALEC) - Defense World
Alector, Inc. (NASDAQ:ALEC) Shares Sold by Charles Schwab Investment Management Inc. - The AM Reporter
Alector Announces Resignation of Chief Medical Officer - TipRanks
Alector Appoints New Chief Medical Officer - MarketScreener
Alector Provides Executive Leadership Update - The Manila Times
Alector Names Neurology Expert as CMO Amid Crucial Phase 3 Dementia Trial - Stock Titan
Alector Cuts Staff Again, This Time Laying Off 13% of Workforce - BioSpace
Alector, Inc. (NASDAQ:ALEC) Not Doing Enough For Some Investors As Its Shares Slump 26% - simplywall.st
Alector stock hits 52-week low at $1.29 amid sharp annual decline - Investing.com Australia
Alector at Virtual CNS Forum: Advancing Neurodegenerative Treatments By Investing.com - Investing.com South Africa
Alector at Virtual CNS Forum: Advancing Neurodegenerative Treatments - Investing.com
Alector: Q4 Of 2025 FTD-GRN Treatment Data Is Important Inflection Point (NASDAQ:ALEC) - Seeking Alpha
Mizuho’s latest rating for ALEC stock - Knox Daily
Alector at Leerink Global Healthcare Conference: Strategic Advances in Neurodegeneration - Investing.com India
Alector announces workforce reduction to cut costs By Investing.com - Investing.com Australia
Alector announces workforce reduction to cut costs - Investing.com
Alector to Cut 13% of Workforce - MarketWatch
Have Alector Insiders Been Selling Stock? - simplywall.st
Alector, Inc. (NASDAQ:ALEC) Receives $3.75 Consensus Target Price from Analysts - Defense World
Alector assumed with an Underweight at Morgan Stanley - TipRanks
Alector at TD Cowen Conference: Advancing Neurodegenerative Therapies - Investing.com India
Alector at TD Cowen Conference: Advancing Neurodegenerative Therapies By Investing.com - Investing.com UK
Alector Executives Sell Shares to Satisfy Tax Obligations - TradingView
Alector stock hits 52-week low at $1.54 amid sharp annual decline - Investing.com Australia
HC Wainwright Brokers Raise Earnings Estimates for Alector - The AM Reporter
Alector stock hits 52-week low at $1.54 amid sharp annual decline By Investing.com - Investing.com South Africa
Research Analysts Set Expectations for Alector Q1 Earnings - Defense World
HC Wainwright Reiterates “Buy” Rating for Alector (NASDAQ:ALEC) - The AM Reporter
Earnings Update: Alector, Inc. (NASDAQ:ALEC) Just Reported And Analysts Are Trimming Their Forecasts - Simply Wall St
Alector (NASDAQ:ALEC) Receives "Buy" Rating from HC Wainwright - MarketBeat
Alector Full Year 2024 Earnings: Beats Expectations - Yahoo Finance
Alector’s Earnings Call: Progress Amid Challenges - TipRanks
Alector Inc (ALEC) 財務データ
収益
当期純利益
現金流量
EPS
Alector Inc (ALEC) インサイダートレーディング
インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
---|---|---|---|---|---|---|---|
Rosenthal Arnon | Chief Executive Officer |
Mar 03 '25 |
Sale |
1.47 |
40,330 |
59,176 |
2,466,744 |
GRASSO MARC | Chief Financial Officer |
Mar 03 '25 |
Sale |
1.47 |
18,091 |
26,547 |
312,560 |
Romano Gary | Chief Medical Officer |
Mar 03 '25 |
Sale |
1.47 |
16,306 |
23,927 |
332,977 |
大文字化:
|
ボリューム (24 時間):